Vertex Pharmaceuticals Stock Price History

VRTX Stock  USD 450.97  0.60  0.13%   
Below is the normalized historical share price chart for Vertex Pharmaceuticals extending back to July 24, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Vertex Pharmaceuticals stands at 450.97, as last reported on the 24th of November, with the highest price reaching 457.54 and the lowest price hitting 449.04 during the day.
IPO Date
24th of July 1991
200 Day MA
454.3449
50 Day MA
474.1284
Beta
0.394
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0523, which indicates the firm had a -0.0523% return per unit of risk over the last 3 months. Vertex Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vertex Pharmaceuticals' Coefficient Of Variation of (2,139), risk adjusted performance of (0.03), and Variance of 2.91 to confirm the risk estimate we provide.
  
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024. . At this time, Vertex Pharmaceuticals' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 7.46 in 2024, whereas Price To Sales Ratio is likely to drop 10.09 in 2024. Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0523

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVRTX

Estimated Market Risk

 1.72
  actual daily
15
85% of assets are more volatile

Expected Return

 -0.09
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vertex Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding Vertex Pharmaceuticals to a well-diversified portfolio.
Price Book
7.43
Enterprise Value Ebitda
215.021
Price Sales
10.9298
Shares Float
256.8 M
Wall Street Target Price
514.805

Vertex Pharmaceuticals Stock Price History Chart

There are several ways to analyze Vertex Stock price data. The simplest method is using a basic Vertex candlestick price chart, which shows Vertex Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 8, 2024516.74
Lowest PriceNovember 19, 2024448.01

Vertex Pharmaceuticals November 24, 2024 Stock Price Synopsis

Various analyses of Vertex Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Vertex Stock. It can be used to describe the percentage change in the price of Vertex Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Vertex Stock.
Vertex Pharmaceuticals Price Rate Of Daily Change 1.00 
Vertex Pharmaceuticals Price Action Indicator(2.02)
Vertex Pharmaceuticals Price Daily Balance Of Power 0.07 

Vertex Pharmaceuticals November 24, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Vertex Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Vertex Pharmaceuticals intraday prices and daily technical indicators to check the level of noise trading in Vertex Stock and then apply it to test your longer-term investment strategies against Vertex.

Vertex Stock Price History Data

The price series of Vertex Pharmaceuticals for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 68.73 with a coefficient of variation of 3.01. The daily prices for the period are distributed with arithmetic mean of 475.47. The median price for the last 90 days is 475.7. The company experienced 2:1 stock split on 24th of August 2000.
OpenHighLowCloseVolume
11/24/2024
 454.30  457.54  449.04  450.97 
11/22/2024 454.30  457.54  449.04  450.97  1,264,929 
11/21/2024 454.40  455.43  445.00  450.37  1,492,971 
11/20/2024 448.31  451.76  445.38  451.23  1,642,030 
11/19/2024 462.80  463.85  447.14  448.01  2,174,927 
11/18/2024 465.07  468.88  458.05  467.01  1,094,934 
11/15/2024 478.93  479.94  458.10  465.70  2,550,096 
11/14/2024 495.62  495.62  483.56  483.96  1,157,967 
11/13/2024 491.66  498.25  491.24  494.61  962,866 
11/12/2024 503.00  507.58  489.02  490.00  1,191,537 
11/11/2024 518.27  518.35  500.14  501.72  1,313,151 
11/08/2024 507.17  519.88  504.94  516.74  1,166,113 
11/07/2024 493.70  504.31  488.06  502.45  968,912 
11/06/2024 505.78  506.65  485.52  493.64  1,646,181 
11/05/2024 483.00  503.21  474.00  499.88  1,722,417 
11/04/2024 472.79  475.48  468.87  472.80  1,246,781 
11/01/2024 471.06  475.49  463.14  471.12  1,230,238 
10/31/2024 471.58  477.70  468.98  475.98  1,367,277 
10/30/2024 470.44  475.46  469.00  475.08  719,223 
10/29/2024 476.33  478.06  469.62  470.36  999,531 
10/28/2024 477.95  478.06  474.69  476.37  490,273 
10/25/2024 477.20  480.41  475.34  477.70  1,015,533 
10/24/2024 473.34  477.84  471.90  471.91  674,011 
10/23/2024 474.47  476.54  464.78  470.05  990,122 
10/22/2024 479.43  482.87  473.58  474.91  1,110,442 
10/21/2024 483.00  487.83  477.66  478.09  680,215 
10/18/2024 498.30  498.30  480.79  483.00  2,243,896 
10/17/2024 490.00  499.09  487.96  498.73  1,001,252 
10/16/2024 481.79  488.48  480.70  487.25  711,907 
10/15/2024 487.01  488.00  480.79  484.30  1,250,974 
10/14/2024 481.64  487.09  478.90  484.82  710,797 
10/11/2024 478.53  482.89  475.87  481.71  935,108 
10/10/2024 467.49  477.00  464.85  476.15  1,077,746 
10/09/2024 460.00  468.16  456.16  467.97  987,433 
10/08/2024 451.98  459.85  451.11  458.94  1,293,875 
10/07/2024 454.17  454.30  447.73  448.60  881,943 
10/04/2024 454.98  458.14  452.62  455.31  779,678 
10/03/2024 460.00  462.13  452.26  453.55  963,801 
10/02/2024 461.66  468.07  460.55  462.14  896,851 
10/01/2024 472.00  472.31  461.36  469.76  1,121,051 
09/30/2024 463.16  467.57  461.41  465.08  798,430 
09/27/2024 466.01  467.57  461.49  462.88  708,658 
09/26/2024 462.08  465.32  458.10  463.15  870,713 
09/25/2024 463.09  464.88  458.54  461.76  778,058 
09/24/2024 459.59  466.09  456.07  462.99  1,254,724 
09/23/2024 464.92  465.18  458.55  460.00  874,186 
09/20/2024 474.36  474.93  463.81  464.92  2,238,420 
09/19/2024 477.70  483.98  476.27  477.90  938,354 
09/18/2024 483.78  483.78  473.75  474.16  868,105 
09/17/2024 486.42  486.42  477.23  481.26  1,266,155 
09/16/2024 490.00  490.15  484.00  489.43  587,965 
09/13/2024 480.00  486.06  478.75  485.37  697,521 
09/12/2024 474.74  479.51  468.46  478.65  735,662 
09/11/2024 471.53  476.11  460.69  474.74  941,830 
09/10/2024 471.53  473.11  466.03  470.78  720,052 
09/09/2024 472.23  473.68  468.97  471.11  771,391 
09/06/2024 467.92  471.89  463.04  468.00  1,085,398 
09/05/2024 477.73  477.73  463.41  468.57  793,418 
09/04/2024 476.82  480.14  472.97  478.57  868,281 
09/03/2024 492.65  492.66  474.58  475.70  1,762,847 
08/30/2024 495.67  500.21  492.29  495.89  1,808,863 

About Vertex Pharmaceuticals Stock history

Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
Last ReportedProjected for Next Year
Common Stock Shares Outstanding260.5 M153.1 M
Net Income Applicable To Common Shares3.8 BB

Vertex Pharmaceuticals Quarterly Net Working Capital

5.83 Billion

Vertex Pharmaceuticals Stock Technical Analysis

Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Vertex Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Vertex Stock Analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.